N-(3-(5-Chloro-2-(difluoromethoxy)phenyl)-1-(2-(4-((2-cyanoethyl)(methyl)amino)piperidin-1-yl)-2-oxoethyl)-1H-pyrazol-4-yl)pyrazolo[1,5-a]pyrimidine-3-carboxamide
97%
- Product Code: 214770
CAS:
1831144-46-7
| Molecular Weight: | 612.03 g./mol | Molecular Formula: | C₂₈H₂₈ClF₂N₉O₃ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | 1.47±0.1 g/cm3(Predicted) | Storage Condition: | 2-8°C, Inert Gas |
Product Description:
Used in pharmaceutical research as a potent and selective inhibitor of Janus kinase 1 (JAK1), showing promise in the treatment of autoimmune and inflammatory diseases such as rheumatoid arthritis, psoriasis, and inflammatory bowel disease. Its structure enables high selectivity for JAK1 over other JAK family members, potentially reducing side effects commonly associated with broader JAK inhibition. Currently investigated in preclinical and clinical studies for its efficacy, pharmacokinetic profile, and safety in modulating immune responses. Also serves as a lead compound for developing new oral therapies targeting cytokine signaling pathways involved in chronic inflammation.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 100mg | 10-20 days | €2,057.12 |
+
-
|
| 250mg | 10-20 days | €3,085.41 |
+
-
|
| 1g | 10-20 days | €4,348.25 |
+
-
|
N-(3-(5-Chloro-2-(difluoromethoxy)phenyl)-1-(2-(4-((2-cyanoethyl)(methyl)amino)piperidin-1-yl)-2-oxoethyl)-1H-pyrazol-4-yl)pyrazolo[1,5-a]pyrimidine-3-carboxamide
Used in pharmaceutical research as a potent and selective inhibitor of Janus kinase 1 (JAK1), showing promise in the treatment of autoimmune and inflammatory diseases such as rheumatoid arthritis, psoriasis, and inflammatory bowel disease. Its structure enables high selectivity for JAK1 over other JAK family members, potentially reducing side effects commonly associated with broader JAK inhibition. Currently investigated in preclinical and clinical studies for its efficacy, pharmacokinetic profile, and safety in modulating immune responses. Also serves as a lead compound for developing new oral therapies targeting cytokine signaling pathways involved in chronic inflammation.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
€0.00
€0.00
Total :